Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 1/2a Study of PGT121, VRC07-523LS and PGDM1400 Monoclonal Antibodies in HIV-uninfected and HIV-infected Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03721510
Recruitment Status : Recruiting
First Posted : October 26, 2018
Last Update Posted : March 15, 2021
Sponsor:
Collaborators:
Beth Israel Deaconess Medical Center
National Institute of Allergy and Infectious Diseases (NIAID)
Orlando Immunology Center
Houston AIDS Research Team
Information provided by (Responsible Party):
International AIDS Vaccine Initiative

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 2022
Estimated Study Completion Date : October 2022